TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients

Resistance to radio and chemotherapy is one of the major drawbacks in the progression of head and neck squamous cell cancer (HNSCC) patients, evidencing the importance of finding optimum molecular prognosis markers to develop personalized treatment schedules. TGF-β effector TAK1 activity has been re...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Honorato-Cía, B. (Beatriz), Alcalde, J. (Juan), Martinez-Monge, R. (Rafael), Garcia-Foncillas, J. (Jesús), Zabalegui, N. (Natalia)
Formatua: info:eu-repo/semantics/article
Hizkuntza:eng
Argitaratua: Libertas Academica 2012
Gaiak:
Sarrera elektronikoa:https://hdl.handle.net/10171/23495